NTRA: Natera, Inc. Stock

SIC 8071 – Medical Laboratories

Valuation
Market Cap ($M) 14,532.57
Enterprise Value ($M) 14,099.76
Book Value ($M) 836.52
Book Value / Share 6.76
Price / Book 17.37
NCAV ($M) 621.35
NCAV / Share 5.02
Price / NCAV 23.39

Profitability (mra)
Return on Invested Capital (ROIC) -0.23
Return on Assets (ROA) -0.23
Return on Equity (ROE) -0.49

Liquidity (mrq)
Quick Ratio 4.01
Current Ratio 4.14

Balance Sheet (mrq) ($M)
Current Assets 1,301.82
Assets 1,516.99
Liabilities 680.47
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 1,082.57
Operating Income -446.25
Net Income -434.80
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -246.96
Cash from Investing 168.50
Cash from Financing 254.46

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
06-07 13G/A Jpmorgan Chase & Co 4.30 -33.01
02-14 13G/A Alger Associates Inc 5.90 -21.14
02-13 13G/A Vanguard Group Inc 9.13 10.32
01-31 13G BlackRock Inc. 5.20 14.46

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-08-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-05-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-02-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-09-06 139,713 807,106 17.31
2024-09-05 237,074 917,504 25.84
2024-09-04 174,950 855,317 20.45
2024-09-03 105,049 701,789 14.97

(click for more detail)

Similar Companies
FTRE – Fortrea Holdings Inc. GH – Guardant Health, Inc.


Financial data and stock pages provided by
Fintel.io